Physician profile
Michael Eugene Johnson
NPI 1962964015
$2,243.42
in general payments reported to CMS, 2019-2025
21 companies · $18.47 in 2025
The $18.47 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,225 · 2025: $18.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $303.54 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $242.36 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $221.03 | 2021 | |
| Csl Behring | $203.42 | 2021 | |
| Ucb, INC. | $178.93 | 2021 | |
| Allergan, INC. | $177.60 | 2021 | |
| Alexion Pharmaceuticals, INC. | $125.86 | 2021 | |
| Arbor Pharmaceuticals, INC. | $115.39 | 2021 | |
| Biogen, INC. | $98.83 | 2021 | |
| Genzyme Corporation | $98.74 | 2021 | |
| Amgen INC. | $94.90 | 2021 | |
| Merz Pharmaceuticals, LLC | $80.32 | 2021 | |
| Amneal Pharmaceuticals LLC | $78.58 | 2021 | |
| Sk Life Science, INC. | $64.40 | 2021 | |
| Lilly USA, LLC | $37.92 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $35.11 | 2021 | |
| Neurelis, INC. | $28.45 | 2021 | |
| Currax Pharmaceuticals LLC | $16.41 | 2021 | |
| Avanir Pharmaceuticals, INC. | $14.40 | 2021 | |
| Merck Sharp & Dohme LLC | $13.80 | 2021 | |
| Upsher-Smith Laboratories LLC | $13.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.